Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's disease

Cancer. 1984 Apr 1;53(7):1507-8. doi: 10.1002/1097-0142(19840401)53:7<1507::aid-cncr2820530714>3.0.co;2-d.

Abstract

A patient with Hodgkin's disease entered complete clinical remission by combination radiochemotherapy. He developed dyshematopoiesis 1.5 years later and an overt acute nonlymphocytic leukemia 3 years after diagnosis. A complete remission was achieved following 2 courses of intensive polychemotherapy. Four months later, while still in remission, he underwent an allogeneic bone marrow transplantation (BMT) from an HLA-identical sister. Mild chronic graft versus host disease of the skin occurred 3 months after BMT, and now the patient has been in complete remission of leukemia for over 2 years. This appears to be a unique case of prolonged remission of a leukemia secondary to an intensively treated Hodgkin's disease.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation*
  • Combined Modality Therapy / adverse effects
  • Hodgkin Disease / pathology
  • Hodgkin Disease / therapy*
  • Humans
  • Leukemia, Myeloid / etiology
  • Leukemia, Myeloid / therapy*
  • Male
  • Prognosis
  • Skin Diseases / etiology
  • Transplantation, Homologous / adverse effects